T 1190/10 of 18.03.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T119010.20140318
- Date of decision
- 18 March 2014
- Case number
- T 1190/10
- Petition for review of
- -
- Application number
- 03745193.7
- IPC class
- A61K 31/46A61K 9/72
- Language of proceedings
- German
- Distribution
- No distribution (D)
- Download
- Decision in German
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- HFA-SUSPENSIONSFORMULIERUNGEN ENTHALTEND EIN ANTICHOLINERGIKUM
- Applicant name
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Opponent name
- NORTON HEALTHCARE LIMITED
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Spät eingereichte Beweismittel
Neuheit - (ja)
Erfinderische Tätigkeit - nicht naheliegende Alternative - Catchword
- -
- Cited cases
- T 0640/91
- Citing cases
- -
Entscheidungsformel
Aus diesen Gründen wird entschieden:
Die Beschwerde wird zurückgewiesen.